Norit Carbomix (Charcoal, Activated)

Activated charcoal works by providing a highly porous carbon surface that physically adsorbs a broad spectrum of organic molecules, gases and electrolytes present in the gut. This non‑selective binding prevents the substances from being absorbed into the bloodstream, thereby limiting systemic toxicity or gas‑related discomfort.

The dose of Norit Carbomix is determined by the prescribing healthcare professional based on the specific clinical situation, the amount of toxin ingested, the patient’s age, weight and overall health. No fixed regimen is provided here; the prescriber will set the appropriate amount and timing.

Safety data for activated charcoal in pregnancy and lactation are limited. It should only be used when clearly needed and after a careful risk‑benefit assessment by a qualified clinician. The prescriber will decide if the potential benefits outweigh any possible risks to the mother or infant.

To order Norit Carbomix, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any required import documentation.

Norit Carbomix (activated charcoal) is a non‑specific adsorbent that can bind a wide range of toxins, whereas other agents such as sodium bicarbonate or specific antidotes target particular substances. Charcoal offers broad‑spectrum coverage but may interfere with the absorption of concomitant oral medications, a consideration not usually relevant with more selective treatments.

Store Norit Carbomix at ambient temperature, preferably below 25 °C, in its original packaging. Protect the product from moisture, humidity and direct sunlight to maintain its adsorptive capacity. Keep it out of reach of children and ensure the container is tightly closed after each use.

Norit Carbomix is administered orally, typically as a powder mixed with water or another suitable liquid to form a suspension. The mixture should be ingested promptly after preparation, and patients are advised to avoid eating or drinking other substances for at least two hours to maximize adsorption.

The most serious risks include aspiration pneumonia if the product is inhaled during vomiting, bowel obstruction from large or repeated doses, and rare electrolyte disturbances due to adsorption of essential ions. Prompt medical evaluation is required if any of these complications are suspected.

Norit Carbomix should be avoided in individuals with known hypersensitivity to activated charcoal, in patients with a compromised airway who are at risk of aspiration, and in those with existing gastrointestinal obstruction. It should also be used with caution in pregnant or breastfeeding women, and only under professional guidance.